Evolent Health, Inc. EVH
3.90 USD +0.47 (+13.70%)
Regular-session close
3.78 -0.12 -3.08%
After hours · Nov 20, 7:43 PM ET
3.45 Day range 4.16
2.10 52-week range 6.26
- YTD
- -2.50%
- 1 year
- +5.69%
EVH revenue history
Revenue is income from the company’s ordinary business activities.
1,876,229,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 1,876,229,000 | -678,512,000 | -26.56% |
| FY 2024 | 2024-12-31 | 2,554,741,000 | 590,845,000 | 30.09% |
| FY 2023 | 2023-12-31 | 1,963,896,000 | 611,883,000 | 45.26% |
| FY 2022 | 2022-12-31 | 1,352,013,000 | 444,056,000 | 48.91% |
| FY 2021 | 2021-12-31 | 907,957,000 | -16,682,000 | -1.80% |
| FY 2020 | 2020-12-31 | 924,639,000 | 237,517,000 | 34.57% |
| FY 2019 | 2019-12-31 | 687,122,000 | 60,059,000 | 9.58% |
| FY 2018 | 2018-12-31 | 627,063,000 | 192,113,000 | 44.17% |
| FY 2017 | 2017-12-31 | 434,950,000 | 180,762,000 | 71.11% |
| FY 2016 | 2016-12-31 | 254,188,000 | 157,310,000 | 162.38% |
| FY 2015 | 2015-12-31 | 96,878,000 | 96,878,000 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | -25,671,000 | -100.00% |
| FY 2013 | 2013-12-31 | 25,671,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-07T07:00:34.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
